Grosmanová T, Tomsu M, Konecný K, Pesula E, Bachleda P
1st Clinic of Surgery, Medical Faculty, Palacký University, Olomouc, Czechoslovakia.
Acta Univ Palacki Olomuc Fac Med. 1991;131:335-42.
Basing on three types of questionnaires, the authors summarized the incidence of all malignant diseases in kidney transplant patients in CSFR. The total number of registered tumours was 34. Previously to the transplantation, two patients with malignancies were found, another one was transplanted for a kidney tumour and 31 patients manifested malignant diseases in various time intervals following the transplantation. This number is five times greater than the incidence of tumours in the standard population. At classical immunosuppression, the mean time interval between transplantation and tumour formation is 48 months; at cyclosporine application, it decreases to 19 months. The most frequent sites of tumour formation are the skin and the kidney. The early diagnosis of tumours and the surgical treatment will increase the survival period up to 58 months. The systematic oncologic follow-up and preventive controls of transplant patients represent one of the possibilities of the prolongation of the patient's life with the functional graft.
基于三种类型的调查问卷,作者总结了捷克斯洛伐克肾移植患者中所有恶性疾病的发病率。登记的肿瘤总数为34例。移植前发现2例患有恶性肿瘤的患者,另1例因肾肿瘤接受移植,31例患者在移植后的不同时间段出现恶性疾病。这个数字比标准人群中肿瘤的发病率高五倍。在传统免疫抑制情况下,移植与肿瘤形成之间的平均时间间隔为48个月;应用环孢素时,该时间间隔降至19个月。肿瘤形成最常见的部位是皮肤和肾脏。肿瘤的早期诊断和手术治疗可将生存期延长至58个月。对移植患者进行系统的肿瘤学随访和预防性检查是延长患者带功能移植物生存期的可能性之一。